LR
Lindsay Rosenwald, M.D.
Chairman, President & Chief Executive Officer, Fortress Biotech, Inc., Chairman, Journey Medical Corporation
Journey MedicalTherapeutic Areas
Journey Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Accutane (Isotretinoin Capsules USP) | Severe Nodular Acne | Approved |
| EMROSI (minocycline hydrochloride) extended-release capsules, 40mg | Inflammatory Lesions (Papules and Pustules) of Rosacea in Adults | Approved |
Leadership Team at Journey Medical
CM
Claude Maraoui
President & Chief Executive Officer
JB
Joseph Benesch
Chief Financial Officer
RN
Robert Nevin
Chief Commercial Officer
RA
Ramsey Alloush
Chief Operating Officer & General Counsel
NH
Neil Herskowitz
Director
MC
Michael C. Pearce
Director
JS
Justin Smith
Director